Breakdown | ||||
Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
3.60B | 3.79B | 4.28B | 4.38B | 3.80B | Gross Profit |
2.41B | 2.33B | 2.81B | 2.89B | 2.51B | EBIT |
243.20M | 107.70M | 318.40M | 384.50M | 277.40M | EBITDA |
339.90M | 413.50M | 582.10M | 577.00M | 476.30M | Net Income Common Stockholders |
-95.00M | 51.30M | 177.10M | 240.10M | 30.10M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
640.40M | 1.26B | 622.20M | 585.20M | 658.40M | Total Assets |
6.68B | 7.15B | 7.87B | 7.42B | 6.99B | Total Debt |
1.91B | 2.38B | 2.29B | 2.04B | 2.17B | Net Debt |
1.28B | 1.79B | 1.67B | 1.46B | 1.52B | Total Liabilities |
3.38B | 3.99B | 4.49B | 4.17B | 4.04B | Stockholders Equity |
3.28B | 3.12B | 3.34B | 3.19B | 2.90B |
Cash Flow | Free Cash Flow | |||
109.60M | 204.20M | 45.80M | 181.60M | 276.10M | Operating Cash Flow |
478.10M | 602.80M | 452.00M | 542.90M | 538.20M | Investing Cash Flow |
-373.00M | 155.50M | -322.60M | -309.60M | -294.70M | Financing Cash Flow |
-78.80M | -930.80M | 102.60M | -341.30M | -216.90M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
56 Neutral | €2.45B | 50.11 | -2.97% | 5.01% | -4.99% | -286.16% | |
51 Neutral | $2.02B | -1.14 | -21.36% | 3.64% | 2.88% | -30.57% | |
€4.57B | 14.44 | 4.87% | 5.97% | ― | ― | ||
€1.40B | 99.41 | 0.92% | 3.08% | ― | ― | ||
€3.62B | 7.95 | 19.37% | 9.60% | ― | ― | ||
€2.53B | 9.39 | 9.58% | 3.47% | ― | ― | ||
€61.87M | ― | -7.68% | ― | ― | ― |
Imerys has filed its 2024 Universal Registration Document with the Autorité des Marchés Financiers, which includes the annual financial report, management report with sustainability information, and details of the company’s share buyback program. This document’s availability underscores Imerys’ commitment to transparency and regulatory compliance, potentially impacting its market positioning and stakeholder confidence.